findinEsegui ricerca
Image

ENTENTE Health Final Conference - Don't miss this opporunity

28-29 April 2015
Barcelona, Spain

Don’t miss out on the one business development opportunity of the year for European Life Sciences TTOs, where Industry & Investors come specifically to meet and develop business with your institutions!  

With a 9 year proven track record And minimal “cost-basis” admission for ENTENTE member TTOs, Academia & Start-ups.

Just €449 for the full programme, including coffee breaks, lunches, and the evening reception!

Join the top healthcare & life sciences TTOs, leading pharma and biotech executives, and top investors, all from across Europe!

More information
 

EXCLUSIVE ACCESS TO EXPERT LED VALUATION WORKSHOP

Learn life sciences valuations directly from the same experts used by Venture Capital investors and Big Pharma.

The ENTENTE Final Conference at TTS Europe features an exclusive workshop led by Venture Valuation of Switzerland. 

Included in the overall programme for all participants.

Access the entire summit, including workshops, for what you might pay for a single webinar on just one of the crucial topics covered.

REGISTER NOW

 

EXCLUSIVE ACCESS TO I.P. WORKSHOP

Learn current & emerging key issues in life sciences Intellectual Property & Patent issues directly from the some of the leading experts in the world advising big pharma and many of the most successful biotech companies and TTOs in the USA:

The ENTENTE Final Conference at TTS Europe features an exclusive workshop led by Kevin Noonan, Partner at MBHB LLC and Editor of PatentDocs, and Paul Tully, Partner MBHB LLC., Chicago, USA

Included in the overall programme for all participants.

Access the entire summit, including workshops, for what you might pay for a single webinar on just one of the crucial topics covered.

REGISTER NOW

 


Share with
. . .
Inside News & Events
This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
 
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA